Anbio Biotechnology (NNNN) Other Accumulated Expenses (2023 - 2025)

Anbio Biotechnology has reported Other Accumulated Expenses for 3 years, with the latest figure at $87836.0 in Q4 2025.

• On a quarterly basis, Other Accumulated Expenses fell 16.33% year-over-year to $87836.0 in Q4 2025; TTM through Dec 2025 was $87836.0, a 16.33% decrease from a year earlier, with the FY2025 full-year figure at $87836.0, down 16.33% from the prior year.
• Other Accumulated Expenses was $87836.0 for Q4 2025 at Anbio Biotechnology, up from $70777.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $165909.0 in Q4 2023, with the low at $70777.0 in Q2 2025.
• Average Other Accumulated Expenses over 3 years is $107375.2, with a median of $96407.5 recorded in 2024.
• The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses sank 36.72% in 2024, then slipped 16.33% in 2025.
• Over 3 years, Other Accumulated Expenses stood at $165909.0 in 2023, then tumbled by 36.72% to $104979.0 in 2024, then decreased by 16.33% to $87836.0 in 2025.
• The last three Other Accumulated Expenses figures came in at $87836.0 (Q4 2025), $70777.0 (Q2 2025), and $104979.0 (Q4 2024), per Business Quant data.